Introdução: A hiperidrose primária (HP) é uma desordem que afeta negativamente a qualidade de vida de seus portadores. A fisiopatologia da HP não é bem compreendida e acredita-se que uma complexa disfunção do sistema nervoso simpático esteja relacionada com sua etiologia. A ressecção de um ou mais gânglios da cadeia simpática torácica constitui-se como o método mais eficiente de controle da HP; apesar disso, pouco se sabe sobre o funcionamento dos gânglios simpáticos em indivíduos normais e em portadores de HP. Objetivos: Analisar a expressão de acetilcolina e das subunidades 3 e 7 de seu receptor nicotínico neuronal em gânglios da cadeia simpática torácica de portadores de HP palmar e comparar estes resultados com os obtidos de não portadores; avaliar se existe diferença de tamanho entre esses gânglios. Métodos: Estudo transversal, no qual foram analisados dois grupos de 20 participantes: no grupo Hiperidrose, portadores de HP palmar, candidatos a simpatectomia torácica; no grupo Controle, doadores falecidos de órgãos sem história prévia de sudorese excessiva. Em todos os indivíduos foram realizados: ressecção do 3º gânglio simpático esquerdo; aferição do maior diâmetro do gânglio; avaliação imunohistoquímica pela quantificação das áreas de expressão forte e fraca de anticorpos primários contra acetilcolina e contra as subunidades 3 e 7 de seu receptor nicotínico neuronal. Resultados: A mediana da idade dos participantes foi menor no grupo Hiperidrose em relação ao Controle; a proporção de homens e mulheres foi de 3:17 no grupo Hiperidrose e 9:11 no Controle. A expressão da subunidade 3 foi semelhante em ambos os grupos (p = 0,78 para expressão forte e p = 0,31 para expressão fraca). A área de expressão forte da subunidade 7 correspondeu a 4,85% da área total em portadores de HP e a 2,34% nos controles (p < 0,001), enquanto a área de expressão fraca foi de 11,48% no grupo Hiperidrose e de 4,59% no Controle (p < 0,001). Expressão forte da acetilcolina foi encontrada em 4,95% da área total no grupo Hiperidrose e 1,19% no Controle (p < 0,001); expressão fraca foi encontrada em 18,55% e 6,77%, respectivamente (p < 0,001). O diâmetro dos gânglios ressecados foi de 0,71cm no grupo Hiperidrose e de 0,53cm no Controle (p < 0,001). Conclusões: Existe um aumento da expressão de acetilcolina e da subunidade 7 do seu receptor nos gânglios simpáticos de portadores de HP; a subunidade 3 do receptor nicotínico de acetilcolina tem expressão semelhante em gânglios simpáticos de portadores de HP e de não portadores; gânglios da cadeia simpática torácica apresentam diâmetro maior em portadores de HP / Introduction: Primary hyperhidrosis (PH) is a disorder that impairs the quality of life of its bearers. The PH physiopathology is not well understood and a complex sympathetic nervous system dysfunction seems to be related with its etiology. The resection of one or more thoracic sympathetic chain ganglia is the most effective PH treatment; however sympathetic ganglia function in normal subjects and in PH patients is unknown. Objectives: Analyzing the immunohistochemical expression of acetylcholine and its neuronal nicotinic receptors 3 and 7 subunits in thoracic sympathetic ganglia of PH patients and compare the results with those obtained from subjects without this disorder; identifying possible differences in size of these ganglia. Methods: Cross-sectional study, in which two groups of 20 subjects were analyzed: the Hyperhidrosis group, with palmar PH patients eligible to thoracic sympathectomy and the Control group, with organ donators after brain death without hyperhidrosis historical. For each subject it were performed: resection of the third left sympathetic ganglion; measurement of the ganglions diameter; immunohistochemical evaluation by quantification of intense and mild expression areas of primary antibodies against acetylcholine and its neuronal nicotinic receptors 3 and 7 subunits. Results: The median of participants age was smaller in Hyperhidrosis group than in Control; the male/female ratio was 3:17 in Hyperhidrosis group and 9:11 in Control. The 3 subunit expression was similar in both groups (p = 0.78 for intense expression and p = 0.31 for mild expression). Intense 7 subunit expression area was 4.85% in PH patients and 2.34% in controls (p < 0.001) whereas mild expression area was 11.48% in Hyperhidrosis group and 4.59% in Control (p < 0.001). Intense acetylcholine expression was found in 4.95% of total area in Hyperhidrosis group and in 1.19% in Control (p < 0.001); mild expression was found in 18.55% and 6.77%, respectively (p < 0.001). Ganglia diameter was 0.71cm in Hyperhidrosis group and 0.53cm in Control (p < 0.001). Conclusions: There is a higher expression of acetylcholine and its neuronal nicotinic receptors 7 subunit in sympathetic ganglia of PH patients; the 3 subunit of the neuronal nicotinic acetylcholine receptor shows similar expression in sympathetic ganglia of PH patients and subjects without this disorder; thoracic sympathetic chain ganglia diameter is bigger in PH patients

Orientador: Léa Rodrigues Simioni / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-18T22:38:09Z (GMT). No. of bitstreams: 1 Moraes_DelkiaSeabrade_M.pdf: 1400052 bytes, checksum: a886434537e4c9307797b649e17cd63c (MD5) Previous issue date: 2011 / Resumo: Bothrops alcatraz é uma serpente do Arquipélago de Alcatrazes no litoral norte do estado de São Paulo, Brasil, recentemente descrita. Neste trabalho foram analisados os efeitos neuromusculares do veneno de B. alcatraz em preparações isoladas de biventer cervicis de pintainho (BC) e nervo frênico-diafragma de camundongo (NFD), sob estimulação elétrica indireta (0.1 Hz; 0.2 ms). Em preparações BC, o veneno causou bloqueio neuromuscular completo e irreversível nas concentrações de 10, 50 e 100 g/ml em 90 ± 2, 80 ± 1 e 50 ± 1 min, respectivamente (n = 6-9). Nestas mesmas concentrações, as respostas contraturantes evocadas pela adição exógena de ACh (110 mM) foram 27±10, 8±4 e 0%, respectivamente, e do KCl (20 mM) em 45±11, 24±6 e 39±7%, respectivamente. O veneno de B. alcatraz mostrou-se pouco ativo na preparação NFD de camundongo, pois mesmo ensaiado na concentração de 100 g/ml (n=4) causou apenas 30±4% de bloqueio neuromuscular após 120 min de incubação. Em preparações BC previamente curarizadas (d-Tc, 10 g/ml), seguida pela adição do veneno (10 g/ml), por 120 min de incubação, observou-se o retorno da resposta contrátil em 81±7% (n= 4), após sucessivas lavagens. O veneno de B. alcatraz exibiu baixa atividade fosfolipásica quando comparado ao veneno de Crotalus durissus terrificus (A425nm 0,06 ± 0,02 vs 0,2 ± 0,03; n = 4). A análise morfológica in vitro da preparação BC, mostrou, em ambas as concentrações de veneno analisadas (10 e 100 g/ml), dano musculares, sendo 18,1±1,5% e 24,7±6,6% (n= 5), respectivamente, quando comparadas ao controle (7,9±2,4%). Paralelamente também foi observado um aumento significativo na medida da liberação de CK, de 1441 ± 173 (10 g/ml) e 1797 ± 343 (100 g/ml) vs 282 ± 27 U/L da preparação controle, aos 120 min. O estudo sobre a neutralização do veneno pelo antiveneno botrópico comercial, mostrou que foram necessárias altas concentrações do antiveneno (15 vezes mais que o recomendado pelo fabricante) para neutralizar a ação do veneno de B. alcatraz (10 g/ml). Conclui-se que o veneno de B. alcatraz promove bloqueio neuromuscular total e irreversível em preparações de ave, por atuar inicialmente nos receptores colinérgicos e por causar efeito miotóxico tardio; todos estes efeitos foram neutralizados pelo antiveneno botrópico comercial dependendo da concentração de veneno utilizada / Abstract: Bothrops alcatraz is a recently described pitviper from the Alcatrazes Archipelago off the northern coast of São Paulo state, Brazil. The neuromuscular effects of B. alcatraz venom were examined in chick isolated biventer cervicis preparations. In indirectly stimulated preparations, venom (10, 50 and 100 g/ml, n=6-9) caused progressive, irreversible neuromuscular blockade that was complete in 90±2, 80±1 and 50±1 min (mean±SEM), respectively. Venom (10 and 100 g/ml) also inhibited contractures to exogenous ACh (110 ?M) (by 73% and 100%, respectively), but only partially inhibited contractures to KCl (20 mM) (by 55% and 61%, respectively). These same venom concentrations increased the proportion of damaged fibers from 7.9±2.4% (saline control) to 18.1±1.5% and 24.7±6.6%, respectively (p<0.05) and increase in the activity of CK release (1441 ± 173 and 1797 ± 343 vs 282 ± 27 U/L respectively). Bothrops alcatraz venom had low PLA2 activity compared to South American rattlesnake (Crotalus durissus terrificus) venom (A425nm 0.06±0.02 vs 0.2±0.03; n=4). Pretreating the preparations with d-tubucurarine (10 g/ml) prevented the neuromuscular blockade. Commercial bothropic antiserum effectively neutralized the neuromuscular action of B. alcatraz venom. In conclusion, B. alcatraz venom causes neuromuscular blockade by interfering with cholinergic receptors but is only mildly myotoxic. Commercial antivenom neutralizes the neuromuscular blockade / Mestrado / Mestre em Farmacologia

Pentameric ligand-gated ion channels (pLGICs) are membrane bound receptors found in the nervous system. They are responsible for detecting neurotransmitters released from neurons and subsequently mediating responses of the cells on which they are found. Thus, pLGICs play an invaluable role in communication between cells of the nervous system and understanding their function is pivotal to understanding how the nervous system works in general. One factor which is known to mediate pLGIC function is lipids found in the membrane environment in which pLGICs are embedded. This dissertation explores the various ways in which lipids interact with and modulate the function of pLGIC. Potential mechanisms and biological consequences of this modulation will be presented and discussed within the context of our current state of knowledge of pLGIC and nervous system function.

Neuronal communication in the mammalian brain relies on the presynaptic release of neurotransmitters which bind to ligand-gated ion channels found on postsynaptic neurons to modulate neuronal excitability. One such neurotransmitter is acetylcholine (ACh), a small molecule that is the signalling messenger of the cholinergic system. The cholinergic system is involved in a variety of behavioural functions including motor activity, sensory function, and higher executive commands. Dopaminergic neurons in the substantia nigra pars compacta (SNc) and the basal ganglia in general have long been implicated in initiation and completion of voluntary movement. Studies have shown that cholinergic neurons from two brainstem nuclei, the laterodorsal tegmental nucleus and the pedunculopontine nucleus, project onto substantia nigra dopaminergic (DA) neurons in the midbrain and release ACh, GABA or both to modulate motor behaviours. However, with prior research primarily focused on demonstrating the phenomenon of co-transmission itself, the subcellular distribution and dynamics of ACh and GABA release onto SN DA neurons receiving co-transmitted inputs largely remains to be investigated. The present study investigates the spatial and physiological properties of ACh/GABA co- transmission from brainstem cholinergic axons synapsing onto medial SN DA neurons to understand its role in tuning the neuron’s excitatory-inhibitory balance. To that end, we developed a channelrhodopsin (ChR2)-based functional input mapping technique with high spatial resolution to probe the dendritic distribution of ACh and GABA synaptic inputs onto DA neurons in ChATcre::ChR2 mice. Using this technique, we discovered three different types of monosynaptic inputs from cholinergic axons onto DA cells: co-transmitted ACh/GABA, GABA only, and ACh only. Furthermore, we revealed a somatodendritic patterning of cholinergic input distribution onto DA cells with a predominant GABA conductance along the lateral dendrites and a soma-centered mix ACh/GABA transmission. Physiological findings were corroborated using immunolabeling against VGAT and VAChT, which showed many closely spatially clustered ACh and GABA- specific cholinergic terminals and few truly colocalized VAChT and VGAT terminals. This result revealed that true co-transmission represents a minority of the presynaptic mode of release from cholinergic axons onto medial SN DA neurons, and that the majority actually share closely spatially clustered ACh and GABA-specific cholinergic terminals. To investigate the dynamic properties of soma-centered ACh/GABA transmission, we restricted our stimulation field to the cell body to measure the contribution of nAChR and GABAR-mediated conductances without recruiting the lateralized population of primary GABA inputs. We then employed a deconvolution method to understand the relative plasticity of contributions of nAChRs and GABARs to ACh/GABA transmission onto DA cells. We confirmed an initial dominant GABAergic component of ACh/GABA transmission that was previously reported. However, we found that the GABAergic contribution had a greater decay compared to the ACh component with repeated stimulations. As such the predominant initial inhibition is followed by a subsequent equalization of excitatory and inhibitory conductances. Finally, we performed similar experiments to compare the short-term plasticity of the isolated GABA conductance during 15 Hz stimulation between the populations of mix ACh/GABA inputs proximally and the population of primary GABA inputs found on the lateral dendrites 160 μm from the cell body. Interestingly, the lateral GABA component was more sustained across repeated stimulations compared to the proximal GABA conductance, suggesting a differential contribution to excitation/inhibition balance by spatially distributed populations of ACh and GABA inputs from cholinergic axons onto the dendrites of medial SN DA neurons. To our knowledge, this is the first study to examine the distribution and dynamics of ACh/GABA transmission onto midbrain DA system using fine-scale ChR2-assisted subcellular input mapping and conductance deconvolution. / Graduate / 2022-04-12

Nicotinic acid-adenine dinucleotide phosphate (NAADP) is a recently described potent intracellular Ca2+-mobilizing messenger active in a wide range of diverse cell types. In the present study, we have investigated the interaction of NAADP with other Ca2+-mobilizing messengers in the release of transmitter at the frog neuromuscular junction. We show, for the first time, that NAADP enhances neurosecretion in response to inositol 1,4,5-trisphosphate (IP3), cADP-ribose (cADPR) and sphingosine 1-phosphate (S1P), but not sphingosylphosphorylcholine. Thapsigargin was without effect on transmitter release in response to NAADP, but blocked the responses to subsequent application of IP3, cADPR and S1P and their potentiation by NAADP. Asynchronous neurotransmitter release may therefore involve functional coupling of endoplasmic reticulum Ca2+ stores with distinct Ca2+ stores targeted by NAADP.

The purpose of this study was to test the hypothesis that early-stage heart failure differentially affects the intrinsic cardiac nervous system's capacity to regulate cardiac function. After 2 wk of rapid ventricular pacing in nine anesthetized canines, cardiac and right atrial neuronal function were evaluated in situ in response to enhanced cardiac sensory inputs, stimulation of extracardiac autonomic efferent neuronal inputs, and close coronary arterial administration of neurochemicals that included nicotine. Right atrial neuronal intracellular electrophysiological properties were then evaluated in vitro in response to synaptic activation and nicotine. Intrinsic cardiac nicotine-sensitive, neuronally induced cardiac responses were also evaluated in eight sham-operated, unpaced animals. Two weeks of rapid ventricular pacing reduced the cardiac index by 54%. Intrinsic cardiac neurons of paced hearts maintained their cardiac mechano- and chemosensory transduction properties in vivo. They also responded normally to sympathetic and parasympathetic preganglionic efferent neuronal inputs, as well as to locally administered α- or β-adrenergic agonists or angiotensin II. The dose of nicotine needed to modify intrinsic cardiac neurons was 50 times greater in failure compared with normal preparations. That dose failed to alter monitored cardiovascular indexes in failing preparations. Phasic and accommodating neurons identified in vitro displayed altered intracellular membrane properties compared with control, including decreased membrane resistance, indicative of reduced excitability. Early-stage heart failure differentially affects the intrinsic cardiac nervous system's capacity to regulate cardiodynamics. While maintaining its capacity to transduce cardiac mechano- and chemosensory inputs, as well as inputs from extracardiac autonomic efferent neurons, intrinsic cardiac nicotine-sensitive, local-circuit neurons differentially remodel such that their capacity to influence cardiodynamics becomes obtunded.

Electrical stimulation of the vagus nerve attenuates tumor necrosis factor (TNF) synthesis by macrophages and reduces the systemic inflammatory response. Current evidence suggests that the α7 nicotinic acetylcholine receptor present in the celiac/superior mesenteric ganglia is a key component in vagus nerve signaling to the spleen; however, there is currently no direct anatomical evidence that the α7 receptor is present in the murine celiac/superior mesenteric ganglia. Our study addresses this deficiency by providing anatomical evidence that the α7 receptor is expressed within the celiac/superior mesenteric ganglia and splenic nerve fibers using immunohistochemistry and quantitative polymerase chain reaction (qPCR). α7 receptor mRNA is highly expressed in the celiac/superior mesenteric ganglia and at low levels in the spleen compared to the brain. Double-labeling for α7 and tyrosine hydroxylase shows that α7 receptor protein is present on noradrenergic neurons within the ganglia and prejunctionally on noradrenergic nerve fibers within the spleen. The α7 receptor in the ganglia provides a possible location for the action of α7-selective agonists, while prejunctional α7 receptor expressed on splenic nerves may induce an increase in norepinephrine release in a positive feedback system enhanced by lymphocyte-derived acetylcholine.

This review is a brief summary of the effects of nicotine on neural plasticity and behavior, with a focus on the preclinical literature and the effects of nicotine on neurotrophic factors. Focus areas include underlying mechanisms of nicotine addiction and the therapeutic potential for nicotine and nicotinic receptor agonists in Parkinson’s disease, Alzheimer’s disease, traumatic brain injury, as well as cutting across these different areas of research with a brief review of the antiinflammatory effects of nicotine. It is clear that agonists at nicotinic receptors have therapeutic potential, but this should be weighed in the context of the effects of nicotine across the brain and its enhancement of neurotrophic factors. Although nicotine may have neuroprotective properties, it is important to keep in mind that these same effects underlie its addictive characteristics.

The nervous system and immune system have broad and overlapping distributions in the body, and interactions of these ubiquitous systems are central to the field of neuroimmunology. Over the past two decades, there has been explosive growth in our understanding of neuroanatomical, cellular, and molecular mechanisms that mediate central modulation of immune functions through the autonomic nervous system. A major catalyst for growth in this field was the discovery that vagal nerve stimulation (VNS) caused a prominent attenuation of the systemic inflammatory response evoked by endotoxin in experimental animals. This effect was mediated by acetylcholine (ACh) stimulation of nicotinic receptors on splenic macrophages. Hence, the circuit was dubbed the “cholinergic anti-inflammatory pathway”. Subsequent work identified the α7 nicotinic ACh receptor (α7nAChR) as the crucial target for attenuation of pro-inflammatory cytokine release from macrophages and dendritic cells. Further investigation made the important discovery that cholinergic T cells within the spleen and not cholinergic nerve cells were the source of ACh that stimulated α7 receptors on splenic macrophages. Given the important role that inflammation plays in numerous disease processes, cholinergic anti-inflammatory mechanisms are under intensive investigation from a basic science perspective and in translational studies of animal models of diseases such as inflammatory bowel disease and rheumatoid arthritis. This basic work has already fostered several clinical trials examining the efficacy of VNS and cholinergic therapeutics in human inflammatory diseases. This review provides an overview of basic and translational aspects of the cholinergic anti-inflammatory response and relevant pharmacology of drugs acting at the α7nAChR.

While it is clear that most drugs of abuse act to increase extracellular dopamine levels in the nucleus accumbens (NAc), the molecular mechanisms mediating this process vary depending on the molecular target each drug acts on. The rewarding properties of most drugs of abuse including cocaine, amphetamine, and heroin have been well established for some time; however, the molecular mechanisms by which ethanol acts to mediate reward have not been fully elucidated. In this thesis, I have examined the role of nicotinic acetylcholine receptors (nAChRs), known molecular targets for nicotine addiction, in mediating the initial rewarding properties of alcohol. Using a mouse model of voluntary ethanol consumption called Drinking in the Dark (DID), in combination with nAChR pharmacology and mouse genetics, we have provided further evidence for the role of nAChRs in mediating the initial rewardingproperties of ethanol. Because of the vast number of possible functional nAChR subtypes present in the brain, I sought to investigate which subtype of nAChR may be responsible for ethanol reinforcement. To accomplish this, I used twocomplementary nAChR mouse models. The first is a knock-out line that does not express the α4 subunit (α4 KO) and the second is a knock-in line that expresses α4* nAChRs that are hypersensitive to agonist (Leu9′Ala). We have also shown, for the first time, that a specific nAChR subtype, those that contain the α4 subunit (α4*), mediate voluntary ethanol consumption and reward. Next, I examined the role of α4* nAChRs in modulating voluntary ethanol consumption after systemic administration of the FDA approved smoking cessation drug varenicline, a partial agonist of α4* nAChRs. We showed that varenicline and nicotine both reduced acute ethanol consumption in an α4* nAChR dependent mechanism. Taken together, our data indicate that activation of α4* nAChRs is necessary and sufficient for reduction of ethanol consumption and further supports the hypothesis that α4* nAChRs are molecular targets for alcohol cessation therapies.